Vivek Subbiah: This is the equity gap – and it’s costing lives
Vivek Subbiah shared a post on X/Twitter:
“Half the world’s population lacks access to the full range of essential health services.
When it comes to cancer, many of us are denied basic care, even though we live in a time of awe-inspiring advancements in cancer prevention, diagnosis and treatment.
This is the equity gap – and it’s costing lives. By implementing resource-appropriate strategies for prevention, early detection, treatment and care, we can save millions of lives every year.
The Union for International Cancer Control (UICC), the organiser of World Cancer Day, encourages everyone to ask their governments to improve health equity, make it easier for all populations to enjoy affordable and accessible cancer services, and reduce disparities in cancer incidence and mortality
The World Cancer Day 2024 Campaign video is available to watch now!”
Source: Vivek Subbiah/X
Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute. He is the former Executive Director of Oncology Research at the MD Anderson Cancer Network and a former Associate Professor in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center. Dr. Subbiah’s research interests include drug development in rare cancers, immunotherapy, and radiopharmaceuticals.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023